TRE in Type 2 Diabetes (See Food Study 3) (SFS3)

  • End date
    Apr 30, 2025
  • participants needed
  • sponsor
    University of Minnesota
Updated on 9 July 2022
Accepts healthy volunteers


Hyperglycemia in patients with Type 2 Diabetes Mellitus is initially treated with metformin coupled with intentional caloric restriction, which is difficult to sustain due to multiple barriers, including acquiring the necessary knowledge, teaching the intervention, cost of delivery and potential burden on quality of life. In contrast to intentionally restricting calories, time restricted eating (TRE), presents a simplified view of eating focused on restricting the eating window, which allows ad libitum intake per a person's dietary preferences during a daily fixed eating window. This study proposes a 24 week feasibility study to test if TRE is a viable alternative to Caloric Restriction in improving glycemic measures while accounting for weight loss in overweight/obese patients [BMI:25-35 kg/m2] with metformin-only treated Type 2 diabetes.

Condition Type2Diabetes
Treatment Time Restricted Eating, Caloric reduction
Clinical Study IdentifierNCT05290246
SponsorUniversity of Minnesota
Last Modified on9 July 2022


Yes No Not Sure

Inclusion Criteria

Overweight/obese adults with metformin-only treated type 2 diabetes
-50 years old
BMI:25-35 kg/m2
HbA1c: 6.5-8.5%
duration of diabetes ≤10 years
Self-reported weight must be stable [±5 pounds] for at least 3 months prior to the study
Owns a smartphone

Exclusion Criteria

Active or anticipated pregnancy during the study
type 2 diabetes treated with medications other than metformin
presence of eating disorders as noted by screening survey
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact



Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note